IOL CHEMICALS & PHARM. | ZENITH HEALTH | IOL CHEMICALS & PHARM./ ZENITH HEALTH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.4 | 95.7 | 14.0% | View Chart |
P/BV | x | 1.5 | 3.3 | 45.9% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. ZENITH HEALTH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ZENITH HEALTH Mar-23 |
IOL CHEMICALS & PHARM./ ZENITH HEALTH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 8 | 6,943.1% | |
Low | Rs | 272 | 4 | 7,416.9% | |
Sales per share (Unadj.) | Rs | 377.6 | 2.4 | 15,457.6% | |
Earnings per share (Unadj.) | Rs | 23.7 | 0 | 163,283.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 0.1 | 47,378.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 1.3 | 19,083.1% | |
Shares outstanding (eoy) | m | 58.71 | 53.74 | 109.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.3 | 45.9% | |
Avg P/E ratio | x | 17.1 | 394.0 | 4.3% | |
P/CF ratio (eoy) | x | 12.8 | 85.6 | 15.0% | |
Price / Book Value ratio | x | 1.6 | 4.2 | 37.2% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 306 | 7,751.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 13 | 13,131.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 131 | 16,887.1% | |
Other income | Rs m | 256 | 4 | 6,811.2% | |
Total revenues | Rs m | 22,427 | 135 | 16,606.6% | |
Gross profit | Rs m | 2,257 | 0 | 752,233.3% | |
Depreciation | Rs m | 462 | 3 | 16,485.7% | |
Interest | Rs m | 165 | 0 | 235,285.7% | |
Profit before tax | Rs m | 1,887 | 1 | 159,872.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | 123,775.0% | |
Profit after tax | Rs m | 1,391 | 1 | 178,384.6% | |
Gross profit margin | % | 10.2 | 0.2 | 4,499.5% | |
Effective tax rate | % | 26.2 | 34.2 | 76.8% | |
Net profit margin | % | 6.3 | 0.6 | 1,059.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 71 | 13,542.3% | |
Current liabilities | Rs m | 5,025 | 20 | 24,926.6% | |
Net working cap to sales | % | 20.9 | 39.0 | 53.7% | |
Current ratio | x | 1.9 | 3.5 | 54.3% | |
Inventory Days | Days | 43 | 14 | 315.0% | |
Debtors Days | Days | 8 | 643 | 1.3% | |
Net fixed assets | Rs m | 11,017 | 20 | 55,169.8% | |
Share capital | Rs m | 587 | 54 | 1,092.5% | |
"Free" reserves | Rs m | 14,490 | 19 | 77,987.6% | |
Net worth | Rs m | 15,077 | 72 | 20,847.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 91 | 22,642.5% | |
Interest coverage | x | 12.5 | 17.9 | 69.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.4 | 74.6% | |
Return on assets | % | 7.5 | 0.9 | 807.6% | |
Return on equity | % | 9.2 | 1.1 | 857.8% | |
Return on capital | % | 13.6 | 1.7 | 784.6% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 64 | 9,325.5% | |
Fx outflow | Rs m | 6,052 | 0 | 3,025,900.0% | |
Net fx | Rs m | -122 | 63 | -192.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -9 | -13,218.4% | |
From Investments | Rs m | -1,200 | NA | 400,000.0% | |
From Financial Activity | Rs m | -41 | NA | - | |
Net Cashflow | Rs m | -18 | -10 | 192.7% |
Indian Promoters | % | 48.2 | 28.7 | 167.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.4 | 435.9% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 71.3 | 72.7% | |
Shareholders | 130,003 | 33,879 | 383.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ZENITH HEALTH | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.72% | 0.45% | 0.35% |
1-Month | 8.24% | 2.76% | 2.33% |
1-Year | 2.84% | 6.94% | 54.34% |
3-Year CAGR | -12.21% | -12.18% | 15.02% |
5-Year CAGR | 15.09% | 11.88% | 19.24% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ZENITH HEALTH share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ZENITH HEALTH the stake stands at 28.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ZENITH HEALTH.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ZENITH HEALTH paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ZENITH HEALTH.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets Slipped further as the session progressed and ended the day weak.